Teko e potlakileng ea Influenza A+B Antigen Rapid e lekoa ha e bapisoa le RT-PCR.Li-swabs tsa nasopharyngeal tse 539 le li-oropharyngeal swabs li ile tsa hlahlojoa ka Tlhahlobo e potlakileng ea Influenza A + B.
Lintho | Ho tsepamisa maikutlo | Lintho | Ho tsepamisa maikutlo |
Sefafatsi sa Nasal | 15% v/v | Hemoglobin | 10% v/v |
Mucin | 0.5 % w/v | Mupirocin | 10 mg / mL |
Marotholi a Linko | 15% v/v | Hlatsoa molomo | / |
Chloraseptic | 1.5 mg/mL | Levofloxacin | 40 ug/mL |
Oseltamivir | 2ug/mL | Ribavirin | 0.2ug/mL |
Fluticasone propionate | 5% v/v | Ceftriaxone | 800 ug/mL |
Tobramycin | 4ug/mL | Saline Nasal Spray | 10% v/v |
Bakeng sa Influenza A
Mokhoa | RT-PCR | Kakaretso ea Liphetho | ||
Teko e Potlakileng ea Influenza A+B | Liphetho | E ntle | E mpe | |
E ntle | 116 | 1 | 117 | |
E mpe | 5 | 417 | 422 | |
Kakaretso ea Liphetho | 121 | 418 | 539 |
Kutloisiso ea bongaka: 95.87% (95% CI: 90.69% ~ 98.22%)
Tsebo ea bongaka: 99.76% (95% CI: 98.66% ~ 99.96%)
Kakaretso ea sekhahla: 98.89% (95% CI: 97.59% ~ 99.49%).
Bakeng sa Influenza B:
Mokhoa | RT-PCR | Kakaretso ea Liphetho | ||
Teko e Potlakileng ea Influenza A+B | Liphetho | E ntle | E mpe | |
E ntle | 97 | 1 | 98 | |
E mpe | 6 | 435 | 441 | |
Kakaretso ea Liphetho | 103 | 436 | 539 |
Kutloisiso ea bongaka: 94.17% (95% CI: 87.87% ~ 97.30%)
Tsebo ea bongaka: 99.77% (95% CI: 98.71% ~ 99.96%)
Kakaretso ea sekhahla: 98.70% (95% CI: 97.34% ~ 99.37%).
Analytical Sensitivity/LOD
Hangzhou Aichek Medical Technology CO., Ltd. Jinxing Cun, Sechaba sa Yuhang, Yuhang Setereke (Bokamoso ba Sci-Tech City), Hangzhou, Zhejiang, PR China | |
SUNGO Europe BV Olympisch Stadion 24, 1076DE Amsterdam, Netherlands |
Moeli oa ho lemoha (LOD) o ile oa khetholloa ka ho hlahloba maemo a fapaneng a kokoana-hloko ea ntaramane A le kokoana-hloko ea ntaramane ea B tekong ea Influenza A+B Antigen Rapid Test.Maemo a tšoailoeng e le maemo a LOD a lekiloeng a thathamisitsoe ka tlase.
Influenza A (H3N2): 5×103 TCID50/mL
Influenza A (H1N1): 2.5×103 TCID50/mL
Influenza A (H1N1 pdm09): 2.5×103 TCID50/mL
Influenza B (Yamagata): 3.5×103 TCID50/mL
Influenza B (Victoria): 1.0×103 TCID50/mL
Lintlha tsa Tlhahlobo (Cross Reactivity)
Ho fumana hore na tlhahlobo e khethehileng ea Influenza A + B Antigen Rapid Test, ho ile ha lekoa likokoana-hloko tse 'maloa tsa commensal kapa pathogenic tse ka bang teng karolong e ka holimo ea phefumoloho.
Mefuta e metle le e mpe e ile ea hlakoloa ka likokoana-hloko tsena li ile tsa hlahlojoa ka bongata ba 106 TCID50/mL, ho kenyeletsoa SARS-CoV-2, Human coronavirus HKU1, OC43, NL63, 229E, MERS, Rhinovirus, Adenovirus, Enterovirus, Metapneumoviruse, Reciflueumoviruse syncytial virus, Mycoplasma pneumonia, Chlamydia pneumonia, Streptococcus pneumonia, Staphylococcus aureus, Mycobacterium lefuba, Haemophilus influenzae, Streptococcus pyogenes.Ha ho ts'ebetso e ts'oanang e bonoang ka Teko e Potlakileng ea Influenza A+B Antigen Rapid.
Influenza A+B Antigen Rapid Test ke lateral flow immunoassay e reretsoeng ho lemoha boleng ba ntaramane A le li-antigen tsa ntaramane ea B ho swab ea nasopharyngeal le swab ea oropharyngeal.
1.Professional Manufacturer, khoebo e "kholo" e tsoetseng pele ea tekhenoloji ea boemo ba naha
2.Deliver thepa e le kopo ea taelo
3.ISO13485, CE, Lokisetsa litokomane tse fapaneng tsa ho romella
4. Araba lipotso tsa bareki nakong ea lihora tse 24